
Quantum, developer of the Epione robotic platform for cancer treatment, said the acquisition supports its strategy of reducing cancer mortality through robot-assisted tumor ablation.

Quantum, developer of the Epione robotic platform for cancer treatment, said the acquisition supports its strategy of reducing cancer mortality through robot-assisted tumor ablation.